The Journal of Clinical Pharmacology

Title Publication Date Language Citations
Danshen: An Overview of Its Chemistry, Pharmacology, Pharmacokinetics, and Clinical Use2005/12/01English987
A Classification of Antiarrhythmic Actions Reassessed After a Decade of New Drugs1984/04/01English491
The Anticholinergic Drug Scale as a Measure of Drug‐Related Anticholinergic Burden: Associations With Serum Anticholinergic Activity2006/12/01English467
Pharmacokinetics and Bioavailability of Quercetin Glycosides in Humans2001/05/01English418
Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual‐Acting Angiotensin Receptor—Neprilysin Inhibitor (ARNi)2010/04/01English380
A Mechanistic Approach to Understanding the Factors Affecting Drug Absorption: A Review of Fundamentals2002/06/01English378
Global Burden of Disease (GBD) for Hepatitis C2004/01/01English353
DHEA and DHEA‐S: A Review1999/04/01English345
Clinical Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Factor Xa Inhibitor Edoxaban in Healthy Volunteers2010/07/01English334
Multiple Drug Resistance in Cancer Revisited: The Cancer Stem Cell Hypothesis2005/08/01English302
Cannabidiol: An Overview of Some Pharmacological Aspects2002/11/01English301
Metabolism and Disposition of the Thienopyridine Antiplatelet Drugs Ticlopidine, Clopidogrel, and Prasugrel in Humans2010/02/01English295
Stability and Performance of a Population Pharmacokinetic Model1997/06/01English274
Pharmacokinetics and Pharmacodynamics of Zoledronic Acid in Cancer Patients with Bone Metastases2002/11/01English273
New Era in Drug Interaction Evaluation: US Food and Drug Administration Update on CYP Enzymes, Transporters, and the Guidance Process2008/06/01English265
Nuclear Receptors and the Regulation of Drug‐Metabolizing Enzymes and Drug Transporters: Implications for Interindividual Variability in Response to Drugs2007/05/01English262
Body Weight Has Limited Influence on the Safety, Tolerability, Pharmacokinetics, or Pharmacodynamics of Rivaroxaban (BAY 59‐7939) in Healthy Subjects2007/02/01English256
Nuclear Factor Kappa B: Important Transcription Factor and Therapeutic Target1998/11/01English255
Effects of Celecoxib, a Novel Cyclooxygenase‐2 Inhibitor, on Platelet Function in Healthy Adults: A Randomized, Controlled Trial2000/02/01English244
Pharmacokinetics and Bioavailability of Mycophenolate Mofetil in Healthy Subjects after Single‐Dose Oral and Intravenous Administration1996/04/01English242
Doxorubicin Encapsulated in Liposomes Containing Surface‐Bound Polyethylene Glycol: Pharmacokinetics, Tumor Localization, and Safety in Patients with AIDS‐Related Kaposi's Sarcoma1996/01/01English237
Dose‐Dependent Pharmacokinetics and Psychomotor Effects of Caffeine in Humans1997/08/01English235
Prediction of Human Pharmacokinetics From Preclinical Information: Comparative Accuracy of Quantitative Prediction Approaches2009/05/01English225
Effects of the Proton Pump Inhibitor Lansoprazole on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel2008/04/01English223
Effects of Nonsteroidal Antiinflammatory Drugs on Platelet Function and Systemic Hemostasis1995/03/01English219
Pharmacokinetic Profile of the Oral Direct Thrombin Inhibitor Dabigatran Etexilate in Healthy Volunteers and Patients Undergoing Total Hip Replacement2005/05/01English211
Human Drug Metabolism and the Cytochromes P450: Application and Relevance of In Vitro Models2001/11/01English210
Comparative Inhibitory Activity of Rofecoxib, Meloxicam, Diclofenac, Ibuprofen, and Naproxen on COX‐2 versus COX‐1 in Healthy Volunteers2000/10/01English210
Hemodynamic Response to the Upright Posture1994/05/01English206
Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end‐stage renal disease on hemodialysis2015/12/22English206